CLASS II ONGOING Device recall · Reported 16 Mar 2022 · FDA Enforcement Report

NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip recalled

NeuMoDx Molecular is recalling NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip, distributed nationwide in the US. The recall was initiated on 21 Jan 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 116305 S/L-02 (Sublot 02),UDI: 10814278020830
Quantity recalled102 boxes

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0738-2022
FDA event ID
89675
Recalling firm
NeuMoDx Molecular, Ann Arbor, MI
Classification
Class II
Status
Ongoing
Recall initiated
21 Jan 2022
FDA classified
8 Mar 2022
Reported
16 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Potency & Assay

Timeline

21 Jan 2022Recall initiated by company
8 Mar 2022Classified by FDA+46 days
16 Mar 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date.

Where it was distributed

US Nationwide distribution in the states of FL, MD, MI, NY.

Nationwide FloridaMarylandMichiganNew York

Questions about this recall

Is NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip recalled?

Yes. NeuMoDx Molecular recalled NeuMoDx Flu A-B/RSV/Sars-CoV-2 Vantage Test Strip on 21 Jan 2022. The recall is Class II and its status is Ongoing. Recall number Z-0738-2022.

Why was it recalled?

A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.

Which lots are affected?

Lot: 116305 S/L-02 (Sublot 02),UDI: 10814278020830

Where was it sold?

US Nationwide distribution in the states of FL, MD, MI, NY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from NeuMoDx Molecular

All 6

Other Insulin Pumps & Glucose Monitors recalls

All 459